Recent months have seen surges of SARS-CoV-2 infection across the globe along with
considerable viral evolution. Extensive mutations in the spike protein of variants B. 1.1. 7 …

Highly transmissible SARS-CoV-2 variants recently identified in India designated B. 1.617
and B. 1.618 have mutations within the spike protein that may contribute to their increased …

The Covid-19 pandemic has ravaged the globe, and its causative agent, SARS-CoV-2,
continues to rage. Prospects of ending this pandemic rest on the development of effective …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B. 1.1. 7 and B. 1.351
variants were first identified in the United Kingdom and South Africa, respectively, and have …

Rapid Emergence and Epidemiologic Characteristics of the SARS-CoV-2 B.1.526 Variant —
New York City, New York, January 1–April 5, 2021 | MMWR Skip directly to site content Skip …

All current vaccines for COVID-19 utilize ancestral SARS-CoV-2 spike with the goal of
generating protective neutralizing antibodies. The recent emergence and rapid spread of …

ABSTRACT DNA sequence analysis recently identified the novel SARS-CoV-2 variant B.
1.526 that is spreading at an alarming rate in the New York City area. Two versions of the …

SARS-CoV-2 infections have surged across the globe in recent months, concomitant with
considerable viral evolution,–. Extensive mutations in the spike protein may threaten the …

The emergence of SARS-CoV-2 variants with mutations in the spike protein is raising
concerns about the efficacy of infection-or vaccine-induced antibodies. We compared …

While the new UK SARS-CoV-2 variant (B. 1.1. 7/VOC-202012/01) continues to cause a
large number of new COVID-19 cases in the UK, 1 focus in the media has currently shifted to …